PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: TCH-HB02

Model Contact
Model: TCH-HB02
Model Contact: Sarah Woodfield
Institution: TCH Liver PDX Program
Email: sewoodfi@texaschildrens.org

Patient Information
Clinical Timeline

Color Keys:
 
 Unknown
 None
 Low
 Moderate
 High
 Very High

Clinical Information at Collection
Pathology Information at Collection

Model Information for Model: TCH-HB02

Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV
There are no omics data for this model.


Histology Information for Model: TCH-HB02
There are no histology images for this model.













Metastasis Information for Model: TCH-HB02
 
Patient
PDX
Lung

Patient Treatment Information for Model: TCH-HB02

Event IdTreatmentTreatment SettingAge at StartAge at EndDuration
15SIOPEL-4Neoadjuvant6.97.1591 days
35CarboplatinAdjuvant7.67.873 days













Please wait...